Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database

A. G. Florek; B. Nardone; S. Thareja; G. Tran; F. J. Giles; D. P. West

doi:10.1111/bjd.15752

Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database

A. G. Florek
, B. Nardone
, S. Thareja
, G. Tran
, F. J. Giles
, D. P. West

Northwestern University Feinberg School of Medicine

Research output: Contribution to a Journal (Peer & Non Peer) › Letter › peer-review

12 Citations (Scopus)

Original language	English
Pages (from-to)	e220-e221
Journal	British Journal of Dermatology
Volume	177
Issue number	5
DOIs	https://doi.org/10.1111/bjd.15752
Publication status	Published - Nov 2017
Externally published	Yes

Access to Document

10.1111/bjd.15752

Cite this

@article{95d4eef318994a1aa51b90cce6b176bb,

title = "Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database",

author = "Florek, \{A. G.\} and B. Nardone and S. Thareja and G. Tran and Giles, \{F. J.\} and West, \{D. P.\}",

year = "2017",

month = nov,

doi = "10.1111/bjd.15752",

language = "English",

volume = "177",

pages = "e220--e221",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "5",

}

Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database. / Florek, A. G.; Nardone, B.; Thareja, S. et al.
In: British Journal of Dermatology, Vol. 177, No. 5, 11.2017, p. e220-e221.

Research output: Contribution to a Journal (Peer & Non Peer) › Letter › peer-review

TY - JOUR

T1 - Malignancies and ustekinumab

T2 - an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database

AU - Florek, A. G.

AU - Nardone, B.

AU - Thareja, S.

AU - Tran, G.

AU - Giles, F. J.

AU - West, D. P.

PY - 2017/11

Y1 - 2017/11

UR - https://www.scopus.com/pages/publications/85035795024

U2 - 10.1111/bjd.15752

DO - 10.1111/bjd.15752

M3 - Letter

C2 - 28646575

AN - SCOPUS:85035795024

SN - 0007-0963

VL - 177

SP - e220-e221

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 5

ER -

Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database

Access to Document

Other files and links

Cite this